share_log

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga ·  May 17 12:31

Gainers

  • Akanda (NASDAQ:AKAN) shares increased by 103.8% to $0.27 during Friday's regular session. The company's market cap stands at $8.6 million.
  • NovaBay Pharmaceuticals (AMEX:NBY) shares rose 48.66% to $0.18. The company's market cap stands at $6.7 million.
  • Pasithea Therapeutics (NASDAQ:KTTA) stock increased by 29.77% to $8.63. The company's market cap stands at $8.9 million. As per the news, the Q1 earnings report came out 3 days ago.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock moved upwards by 27.23% to $1.13. The market value of their outstanding shares is at $6.8 million.
  • Onconetix (NASDAQ:ONCO) stock increased by 26.73% to $0.18. The market value of their outstanding shares is at $3.9 million.
  • Doximity (NYSE:DOCS) stock increased by 17.98% to $28.01. The market value of their outstanding shares is at $5.2 billion. The company's, Q4 earnings came out yesterday.

Losers

  • Lucy Scientific Discovery (NASDAQ:LSDI) shares decreased by 21.1% to $1.25 during Friday's regular session. The company's market cap stands at $2.2 million.
  • SINTX Techs (NASDAQ:SINT) shares decreased by 15.36% to $0.12. The market value of their outstanding shares is at $14.5 million. The company's, Q1 earnings came out 4 days ago.
  • Bone Biologics (NASDAQ:BBLG) shares declined by 15.01% to $1.87. The company's market cap stands at $1.6 million. The company's, Q1 earnings came out 3 days ago.
  • ARCA biopharma (NASDAQ:ABIO) stock decreased by 14.75% to $3.41. The company's market cap stands at $49.4 million.
  • Cardio Diagnostics Hldgs (NASDAQ:CDIO) shares fell 14.19% to $0.72. The company's market cap stands at $15.5 million.
  • Sonoma Pharmaceuticals (NASDAQ:SNOA) shares declined by 13.09% to $0.22. The company's market cap stands at $3.3 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment